The results obtained are reported in Table S1 and accounted for the synthesized compounds 10–18 to compete with the radioligand binding in a concentration-dependent manner with a clear trend in favor of the β 3 -AR over the β 1 and β 2 subtypes.
← all excerpts
Repurposing Drug Metabolites into Dual β-Adrenergic Receptor-Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders.
1
—
—